Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYPRESS: DAPT Duration with CYPHER Stent
NCT00954707Phase 4Unknown
- Sponsor
- Cordis
- Start
- Aug 2009
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel, prasugrel in coronary artery disease (CAD), sponsored by Cordis. Status: unknown.
02
Drugs
clopidogrelprasugrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00954707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00954707.